An experimental drug developed at Northwestern University has demonstrated further promise as an early intervention for ...

Researchers have achieved what once sounded like science fiction: using engineered nanoparticles to restore brain function in ...

New research suggests Alzheimer’s may start far earlier than previously thought, driven by a hidden toxic protein in the brain. Scientists found that an experimental drug, NU-9, blocks this early ...

The findings add to previous research at CU Anschutz which found that Alzheimer’s patients given Leukine showed improvement ...

Quanterix Corporation (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from ...

Explore the potential of experimental drug NU-9 in early Alzheimer's intervention, targeting toxic amyloid beta forms.

Northwestern University scientists are developing an experimental drug that could serve as an early intervention for Alzheimer’s disease.

People given the herpes medication valacyclovir actually experienced worse cognitive decline than those given a placebo.

A new drug targets Alzheimer’s at its earliest, most silent stage — before memory loss ever begins. Credit: Shutterstock. A ...

Scientists at the University of Colorado Anschutz have discovered that while brain neuron changes, including cell loss, may ...

An experimental drug developed at Northwestern University has demonstrated further promise as an early intervention for ...

ATLANTA — The Georgia Chapter of the Alzheimer’s Association released some holiday gift ideas for loved ones living with the ...